Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: An assessment of the comparative effectiveness analysis of surgery and radiation (CEASAR) cohort.
Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Tallman JE, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Barocas DA, Hoffman KE. Wallis CJD, et al. Among authors: tallman je. Urol Oncol. 2022 Feb;40(2):56.e1-56.e8. doi: 10.1016/j.urolonc.2021.04.035. Epub 2021 Jun 19. Urol Oncol. 2022. PMID: 34154899 Free PMC article.
Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer.
Tallman JE, Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Barocas DA, Hoffman KE. Tallman JE, et al. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):80-87. doi: 10.1038/s41391-022-00518-5. Epub 2022 Feb 25. Prostate Cancer Prostatic Dis. 2023. PMID: 35217831
Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer.
Tallman JE, Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Hoffman KE, Barocas DA. Tallman JE, et al. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):787-794. doi: 10.1038/s41391-022-00627-1. Epub 2022 Dec 8. Prostate Cancer Prostatic Dis. 2023. PMID: 36482081
Association between body mass index and localized prostate cancer management and disease-specific quality of life.
Samora NL, Wallis CJD, Huang LC, Tallman JE, Zhao Z, Hoffman K, Morgans A, Cooperberg M, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan S, O'Neil B, Paddock LE, Stroup A, Wu XC, Koyama T, Penson DF, Barocas DA. Samora NL, et al. Among authors: tallman je. BJUI Compass. 2022 Nov 2;4(2):223-233. doi: 10.1002/bco2.197. eCollection 2023 Mar. BJUI Compass. 2022. PMID: 36816144 Free PMC article.
Correction to: Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer.
Tallman JE, Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Hoffman KE, Barocas DA. Tallman JE, et al. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):809. doi: 10.1038/s41391-023-00658-2. Prostate Cancer Prostatic Dis. 2023. PMID: 36890265 No abstract available.
Correction to: Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer.
Tallman JE, Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Barocas DA, Hoffman KE. Tallman JE, et al. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):214. doi: 10.1038/s41391-023-00659-1. Prostate Cancer Prostatic Dis. 2023. PMID: 36914851 No abstract available.
The evolving clinical use of prostate cancer biomarkers.
Samora NL, Tallman JE, Tosoian JJ. Samora NL, et al. Among authors: tallman je. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):386-387. doi: 10.1038/s41391-022-00567-w. Epub 2022 Jul 7. Prostate Cancer Prostatic Dis. 2022. PMID: 35798854 No abstract available.
20 results